Beyond Divestitures: How Flexible Merger Remedies Are Reshaping Cross-Border Investment

Executive Summary

The global antitrust landscape is undergoing a significant shift in how merger remedies are designed and accepted. Enforcement agencies in the United States, Europe, and Asia are increasingly moving beyond traditional divestitures toward more flexible, often behavioral, remedies that can resolve competition concerns without unduly disrupting the economic logic of a transaction. For multinational corporations involved in cross-border deals, this evolution is not just a compliance detail — it is a strategic variable that can determine whether an acquisition, joint venture, or industrial consolidation moves forward. At a time when supply chain resilience, nearshoring, and industrial policy are top priorities in North America, a pragmatic remedy environment could facilitate the capital flows and operational integration needed to strengthen the region's competitive position.

A U.S. Enforcement Shift Toward Pragmatism

According to a June 2026 publication by Skadden, Arps, Slate, Meagher & Flom LLP, the Trump administration has resolved 16 merger investigations with remedies through the Department of Justice and Federal Trade Commission, compared to only one consent decree in the previous administration. This signals a notable openness to remedy negotiations. While structural remedies remain preferred, behavioral commitments are being accepted in specific cases. For example, DOJ's hybrid remedy in the HPE/Juniper deal combined a divestiture with a software license, while FTC approved Omnicom's acquisition of IPG with conduct restrictions. Agency leadership, such as FTC Chairman Andrew Ferguson, have emphasized willingness to entertain remedies early in the review process, a departure from a more litigation-oriented approach.

Europe's Pragmatic Turn

European regulators traditionally favored divestitures as conditions for clearing mergers. But the U.K.'s Competition and Markets Authority has begun to accept behavioral remedies in complex cases, including a network investment commitment package in Vodafone/Three and hybrid carve-out and behavioral remedies in Schlumberger/ChampionX. The CMA's revised merger remedies guidance, published in December 2025, formalizes this flexibility. Meanwhile, the European Commission is updating its merger guidelines with a forward-looking emphasis on innovation, scale, and investment benefits, which could lead to more tailored remedies aligning with evolving industrial and digital policy goals.

Asia Pacific: Behavioral Remedies as Standard Practice

Asian jurisdictions, notably China, have long used behavioral remedies. China's merger control process considers industrial policy alongside traditional competition analysis, making behavioral commitments an essential tool for clearing deals involving foreign companies. South Korea, the Philippines, Vietnam, and Indonesia have adopted similar approaches, particularly in digital and platform sectors. Even Japan, traditionally structural in orientation, permits behavioral remedies in limited situations, such as licensing intellectual property or supplying goods at cost. India has also shown pragmatic flexibility. For global deals that touch the region, nonstructural remedies can reduce deal risk and align with local policy objectives.

Trade Impact: Unlocking Investment in North America

From a trade and industrial perspective, the shift toward more flexible merger remedies is likely to reduce deal uncertainty and encourage investment. For manufacturers expanding across the United States, Canada, and Mexico, an M&A strategy often is central to securing supply chains, entering new markets, or acquiring technology. When a transaction raises antitrust concerns, a rigidly structural remedy mandate can undermine the strategic rationale. Behavioral remedies that preserve operational integration and allow the merged company to pursue efficiency gains can make cross-border deals more viable, ultimately supporting the investment climate. This matters for sectors like automotive, semiconductors, clean energy, and advanced manufacturing, where achieving scale and vertical integration is critical to competing globally.

Regional Perspective: Aligning Remedies with USMCA Goals

Each of the USMCA partners has distinct investment regulations and competition priorities. Yet the trend toward more flexible remedies in major economies could indirectly influence how competition authorities approach mergers with North American dimensions. For instance, a deal involving a Mexican supplier and a U.S. manufacturer might be cleared by U.S. authorities with behavioral commitments that preserve a rival's access to inputs, which could actually support downstream trade. Similarly, Canadian investors acquiring U.S. technology assets might structure remedies in ways that align with broader regional industrial policy interests, such as maintaining local R&D or workforce commitments. Observers and legal advisors suggest that merging parties should prepare remedy frameworks that demonstrate benefits to domestic consumers, suppliers, and the broader industrial ecosystem.

Future Outlook: Toward a More Adaptive Merger Control System

Over the next three to five years, antitrust enforcers in the United States, Europe, and Asia are likely to continue expanding their use of behavioral remedies. As global trade and investment policies become more intertwined with industrial competitiveness, merger control will be expected to recognize efficiencies, innovation, and strategic benefits while still protecting competitive markets. For North America, this could translate into fewer barriers to deals that support reindustrialization, supply chain resilience, and nearshoring. However, companies will need to navigate a multi-jurisdictional patchwork of remedy expectations. Early engagement, a consistent advocacy narrative, and jurisdiction-specific tailoring will become increasingly important for dealmakers.

Conclusion

The globalization of merger control norms is tilting toward flexibility. This is not merely an antitrust development; it has tangible consequences for trade and investment. For businesses seeking to expand across North America and globally, the ability to negotiate workable remedies — and to align those remedies with policy priorities — can be the difference between a completed transaction and a stranded strategy.

---

Source: Skadden Insights, June 2026 – Beyond Divestitures: The Global Shift Toward More Flexible Merger Remedies